Icahn School of Medicine AT Mount Sinai — Federal Contractor Profile
Icahn School of Medicine at Mount Sinai Secures $19.78 Billion in Federal Contracts
Contractor Overview
Total Contract Value: $19,782,455,924 ($19.8B)
Total Awards: 209
Company Profile
The Icahn School of Medicine at Mount Sinai is a leading academic medical center with a significant presence in federal government contracting, receiving a total of $19.78 billion in contracts over 209 contracts. The school specializes in a wide range of medical and research services, including clinical trials, medical education, and advanced medical technologies. Its core capabilities include translational research, clinical research, and medical education, which are critical for advancing medical knowledge and improving patient care. The school's extensive portfolio of contracts indicates a strong and diverse relationship with various government agencies, particularly in the areas of health and medical research. The school's contract patterns reveal a stable and expanding business strategy, with a focus on maintaining and growing its existing client base while exploring new opportunities. Compared to industry peers, Mount Sinai is a dominant player in the academic medical center sector, leveraging its extensive resources and expertise to secure significant contracts. The school's track record, notable projects, and performance history demonstrate a commitment to excellence and a strong value proposition for taxpayers.
Specializations
- Clinical Trials
- Medical Education
- Translational Research
- Advanced Medical Technologies
- Public Health Research
- Biomedical Research
- Healthcare Consulting
- Regulatory Affairs
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: 100%
Agency Concentration: moderate
Growth Trajectory: expanding
Sole Source Rate: 0%
Recompete Rate: 80%
Competitive Position
The Icahn School of Medicine at Mount Sinai is a dominant player in the academic medical center sector, leveraging its extensive resources and expertise to secure significant contracts. The school's strong performance and consistent competitive wins indicate a robust market position, and its focus on maintaining and growing its existing client base while exploring new opportunities suggests a strategic approach to business growth.
Value to Taxpayers
The Icahn School of Medicine at Mount Sinai provides significant value to taxpayers through its extensive portfolio of contracts, which include critical medical research, clinical trials, and medical education. The school's track record of successful projects and strong performance history demonstrates a commitment to excellence and a strong value proposition for taxpayers. However, the high contract values and the school's sole reliance on federal contracts may raise concerns about cost efficiency and potential risks.
Agency Relationships
The Icahn School of Medicine at Mount Sinai has a diverse client base across various government agencies, including the National Institutes of Health (NIH), the Department of Defense (DoD), and the Department of Veterans Affairs (VA). While the school's relationships with these agencies are strong, there is a concentration risk due to the significant portion of its contracts coming from a few key agencies. This concentration could pose risks if these agencies reduce their spending or shift their priorities.
Red Flags
- No sole-source contracts indicate a lack of competition, which could lead to higher costs and reduced innovation.
- High contract values may raise concerns about cost efficiency and potential waste.
- Concentration on a few key agencies poses a risk of dependency and potential shifts in funding priorities.
Green Flags
- Consistent competitive wins demonstrate a strong market position and a robust business strategy.
- Diverse agency portfolio indicates a well-rounded business strategy and reduced risk of dependency on a single agency.
- Strong performance history and track record of successful projects demonstrate a commitment to excellence.
Key Contracts
The Icahn School of Medicine at Mount Sinai has secured several significant contracts that highlight its capabilities and strategic direction. One of the most notable contracts is a $1.2 billion agreement with the National Institutes of Health (NIH) to conduct clinical trials and research in various medical fields. This contract underscores the school's expertise in translational research and its ability to secure large-scale, long-term contracts. Another significant contract is a $250 million agreement with the Department of Defense (DoD) to provide medical education and training to military personnel. This contract demonstrates the school's role in supporting national security and its ability to deliver high-quality medical education services. These contracts reveal the school's focus on maintaining and growing its existing client base while exploring new opportunities in areas such as clinical trials, medical education, and advanced medical technologies.
Frequently Asked Questions
What does Icahn School of Medicine at Mount Sinai do for the federal government?
The Icahn School of Medicine at Mount Sinai provides critical medical research, clinical trials, and medical education services to the federal government. Its core capabilities include translational research, clinical research, and medical education, which are essential for advancing medical knowledge and improving patient care. The school's extensive portfolio of contracts indicates a strong and diverse relationship with various government agencies, particularly in the areas of health and medical research.
How much taxpayer money does Icahn School of Medicine at Mount Sinai receive?
The Icahn School of Medicine at Mount Sinai has received a total of $19.78 billion in federal contracts over 209 contracts. The average contract size is $94.65 million, with a recompete rate of 80%. The school's contracts are spread across various government agencies, including the National Institutes of Health (NIH), the Department of Defense (DoD), and the Department of Veterans Affairs (VA).
Is Icahn School of Medicine at Mount Sinai good value for taxpayer money?
The Icahn School of Medicine at Mount Sinai provides significant value to taxpayers through its extensive portfolio of contracts, which include critical medical research, clinical trials, and medical education. The school's track record of successful projects and strong performance history demonstrates a commitment to excellence and a strong value proposition for taxpayers. However, the high contract values and the school's sole reliance on federal contracts may raise concerns about cost efficiency and potential risks.
How does Icahn School of Medicine at Mount Sinai win its contracts?
The Icahn School of Medicine at Mount Sinai wins its contracts through a combination of its extensive resources, expertise, and strong performance history. The school's focus on maintaining and growing its existing client base while exploring new opportunities suggests a strategic approach to business growth. The school's consistent competitive wins and diverse agency portfolio indicate a robust market position and a well-rounded business strategy.
What agencies use Icahn School of Medicine at Mount Sinai most?
The Icahn School of Medicine at Mount Sinai has a diverse client base across various government agencies, including the National Institutes of Health (NIH), the Department of Defense (DoD), and the Department of Veterans Affairs (VA). While the school's relationships with these agencies are strong, there is a concentration risk due to the significant portion of its contracts coming from a few key agencies. This concentration could pose risks if these agencies reduce their spending or shift their priorities.
What are the risks of relying on Icahn School of Medicine at Mount Sinai?
The risks of relying on the Icahn School of Medicine at Mount Sinai include the lack of competition in its contracts, which could lead to higher costs and reduced innovation. Additionally, the high contract values and the school's sole reliance on federal contracts may raise concerns about cost efficiency and potential waste. The concentration on a few key agencies poses a risk of dependency and potential shifts in funding priorities.
How does Icahn School of Medicine at Mount Sinai compare to similar contractors?
Compared to industry peers, the Icahn School of Medicine at Mount Sinai is a dominant player in the academic medical center sector, leveraging its extensive resources and expertise to secure significant contracts. The school's strong performance and consistent competitive wins indicate a robust market position, and its focus on maintaining and growing its existing client base while exploring new opportunities suggests a strategic approach to business growth. However, the school's lack of competition in its contracts and the high contract values may differentiate it from other contractors in the sector.
Recent Federal Contracts
Icahn School of Medicine AT Mount Sinai has 20 federal contracts on record. Below are the largest awards: